[{"Assets_0_Q2_USD":40946500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1057500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1057100000.0,"StockholdersEquityConverted_0_Q2_USD":14169700000.0,"StockholdersEquity_0_Q2_USD":14100800000.0,"RevenuesConverted_2_Q2_USD":11052600000.0,"RevenuesConverted_1_Q2_USD":5824300000.0,"NetIncomeLossConverted_2_Q2_USD":897200000.0,"NetIncomeLossConverted_1_Q2_USD":1008000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1991000000.0,"EarningsPerShareDiluted_2_Q2_USD":0.85,"EarningsPerShareDiluted_1_Q2_USD":0.95,"EarningsPerShareBasic_2_Q2_USD":0.85,"EarningsPerShareBasic_1_Q2_USD":0.96,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":1.04,"CommonStockDividendsPerShareCashPaid_1_Q2_USD":0.52,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1055000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1055600000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170728"}]